/
Login
Analysis Scores
Damodaran ?
35/100
ROIC banka/finans için tanımsız — mevduat/prim fonlaması borç değil hammaddedir; değerleme öz-sermaye (P/DD) tabanlı yapılır
Dalio Risk ?
90/100
Piotroski ?
2/9
Weak
Previous period ROA data missing (C1 delta-ROA); Operating cash flow data missing (C3, C4); Current ratio data missing (C6); gross profit data missing → margin comparison unavailable (C8); Banka/finans: kaldıraç/cari-oran/marj kriterleri uygulanamaz, skor kalan kriterlere göre normalize edildi
Graham ?
p1.2
Pahalı
Active Metric?
3/4
Confidence?
64%
Valuation
Potential?
-12.6%
DCF Value ?
0.61
Debt Cycle?
Geç Genişleme
Data
Data ?
7825
1995-12-28 → 2026-08-19
Risk Analysis (VaR)
Orta
252 days
Annual Volatility ?
%27.1
VaR 95% ?
%2.68
daily max loss
VaR 99% ?
%3.84
daily max loss
CVaR 95% ?
%3.38
expected loss (tail)
Max Drawdown ?
%19.7
03.02.2026 → 27.03.2026
Skewness ?
0.24
Parametrik%2.68
Historik%2.49
Cornish-Fisher%2.52
Return Distribution
Fundamental & Technical Analysis
TRAMA-99 Trend — Uptrend
Price (110.65), TRAMA-99 line's %10.0 above. Uptrend ongoing; monitor for TRAMA approach for trend change.
Price:: 110.65
TRAMA: 100.5661
Difference: %+10.0
Profitability
Net Profit Margin
%24.3
Net profit margin %24.3 — very strong. Compared to previous quarter +8.1 point increase.
ROE – Özkaynak Getirisi (TTM)
%4.6
ROE %4.6 — low return on equity.
Valuation
P/E Ratio
13.8x
Sector: 14.6x
F/K 13.8x — sector medianna (14.6x) near reasonable levels.
P/B Ratio
1.35x
Sector: 1.61x
PD/DD 1.35x — sector median (1.61x) below or near. Reasonable valuation.
Indebtedness
Debt / Equity
2.00x
Borç/Özkaynak 2.00x — high leverage. Sensitive to debt cycle changes.
Growth
Revenue Growth (YoY)
%+12.7
Revenue YoY %12.7 grew — healthy growth rate.
Net Profit Growth (YoY)
%+117.7
Net profit YoY %117.7 increased (2025/12) — extraordinary profit growth.
Score Explanations
Lothien Robustness
56/100
Good robustness (56/100). The company shows a generally balanced financial profile; some areas have room for improvement.
Strong
Potential
-12.6%
Minus %12.6 expected value (96.65) vs current price comparison. 3/4 valuation models give 'BUY' signal. Model confidence %64.
Components: PE target: 125.14 | P/B target: 136.24 | DCF target: 27.66
Damodaran Valuation
35/100
Low Damodaran score (35/100). DCF analysis does not support current price. Minusk/sorunlu: ROIC banka/finans için tanımsız — mevduat/prim fonlaması borç değil hammaddedir; değerleme öz-sermaye (P/DD) tabanlı yapılır.
Weak
Dalio Risk Analysis
90/100
Low debt risk (90/100).
Leverage: 50/100 | Debt Service: 50/100 | Quality: 90/100
DCF Discounted Cash Flow
0.61
DCF (0.61) current price %99.4 below — cash flows do not support current price.
Current price: 110.65
Debt Cycle Phase
Geç Genişleme
Debt cycle phase: Geç Genişleme
Piotroski F-Score
2/9
Weak Piotroski (2/9). Many balance sheet quality criteria not met. Note: Previous period ROA data missing (C1 delta-ROA); Operating cash flow data missing (C3, C4)
Weak
Graham Intrinsic Value
p1.2
Graham intrinsic value: p1.2. Pahalı
Expensive
⚖️ Sector Comparison
P/E Ratio
13.8x
vs 14.6x
Sector mediannın %5 below — cheap
P/B Ratio
1.35x
vs 1.61x
Compared to sector %16 cheaper (by book value)
Charts
Indicators
BB deviation
?
RSI thresholds
?
LLOY — Participation Finance Compliance
Loading…
The Lothien health scores and analyses on this page are for informational purposes only. They do not constitute investment advice. Please consult a licensed investment advisor before making investment decisions.